Jacek Kubica, MD PhD, FESC (orcid.org/0000-0001-8250-754X; Web of Science ResearcherID D-6906-2014)

About Jacek Kubica, MD PhD, FESC (orcid.org/0000-0001-8250-754X; Web of Science ResearcherID D-6906-2014)

Jacek Kubica, MD PhD, FESC (orcid.org/0000-0001-8250-754X; Web of Science ResearcherID D-6906-2014), With an exceptional h-index of 48 and a recent h-index of 32 (since 2020), a distinguished researcher at Uniwersytet Mikolaja Kopernika w Toruniu, specializes in the field of Cardiology, Clinical pharmacology, Prevention, Thrombosis, Clinical trials.

His recent articles reflect a diverse array of research interests and contributions to the field:

The use of andexanet alpha in the Polish setting: An interdisciplinary protocol. Expert consensus statement of the Polish Cardiac Society

Strategy of lipid-lowering treatment in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators’ viewpoint

Impact of early levosimendan administration in patients with decompensated chronic heart failure on oxidative stress parameters-the rationale and study design.

Cangrelor—Expanding therapeutic options in patients with acute coronary syndrome

Recommendations of Polish Cardiac Society expert regarding the use of andexanet alpha in the Polish context. An interdisciplinary protocol.

A systematic review and meta-analysis of the impact of the pandemic on dispatcher-assisted cardiopulmonary resuscitation

Should dual antiplatelet treatment be guided by lipoprotein (a) concentration?

Gender-Related Effectiveness of Personalized Post-COVID-19 Rehabilitation

Jacek Kubica, MD PhD, FESC (orcid.org/0000-0001-8250-754X; Web of Science ResearcherID D-6906-2014) Information

University

Position

Collegium Medicum Dept. of Cardiology and Internal Medicine

Citations(all)

9495

Citations(since 2020)

4858

Cited By

6528

hIndex(all)

48

hIndex(since 2020)

32

i10Index(all)

172

i10Index(since 2020)

117

Email

University Profile Page

Uniwersytet Mikolaja Kopernika w Toruniu

Google Scholar

View Google Scholar Profile

Jacek Kubica, MD PhD, FESC (orcid.org/0000-0001-8250-754X; Web of Science ResearcherID D-6906-2014) Skills & Research Interests

Cardiology

Clinical pharmacology

Prevention

Thrombosis

Clinical trials

Top articles of Jacek Kubica, MD PhD, FESC (orcid.org/0000-0001-8250-754X; Web of Science ResearcherID D-6906-2014)

Title

Journal

Author(s)

Publication Date

The use of andexanet alpha in the Polish setting: An interdisciplinary protocol. Expert consensus statement of the Polish Cardiac Society

Polish Heart Journal (Kardiologia Polska)

Ewelina Kazimierczyk

Milena Dąbrowska

Marek Gierlotka

Katarzyna Kapica-Topczewska

Bartosz Karaszewski

...

2024

Strategy of lipid-lowering treatment in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators’ viewpoint

Medical Research Journal

Jacek Kubica

Maciej Banach

Piotr Adamski

Andrzej Budaj

Piotr Buszman

...

2024/1/18

Impact of early levosimendan administration in patients with decompensated chronic heart failure on oxidative stress parameters-the rationale and study design.

Medical Research Journal

Ewa Laskowska

Anna Stefańska

Magdalena Krintus

Jacek Kubica

2024/2/15

Cangrelor—Expanding therapeutic options in patients with acute coronary syndrome

Cardiology Journal

Jacek Kubica

Piotr Adamski

Sławomir Dobrzycki

Robert Gajda

Mariusz Gąsior

...

2024

Recommendations of Polish Cardiac Society expert regarding the use of andexanet alpha in the Polish context. An interdisciplinary protocol.

Kardiologia Polska

E Kazimierczyk

M Dąbrowska

M Gierlotka

K Kapica-Topczewska

B Karaszewski

...

2024/1/17

A systematic review and meta-analysis of the impact of the pandemic on dispatcher-assisted cardiopulmonary resuscitation

Jasmine Hui Min Low

Darel Wee Kiat Toh

Magdeline Tao Tao Ng

Johnson Fam

Ee Heok Kua

...

2021/8/25

Should dual antiplatelet treatment be guided by lipoprotein (a) concentration?

Cardiology Journal

Jacek Kubica

2024

Gender-Related Effectiveness of Personalized Post-COVID-19 Rehabilitation

Journal of Clinical Medicine

Alicja Rzepka-Cholasińska

Jakub Ratajczak

Piotr Michalski

Michał Kasprzak

Agata Kosobucka-Ozdoba

...

2024/2/6

Diagnostic and prognostic performance of the neutrophil-to-lymphocyte ratio in acute coronary syndromes: A meta-analysis of 90 studies including 45 990 patients

Polish Heart Journal (Kardiologia Polska)

Michał Pruc

Jacek Kubica

Maciej Banach

Damian Swieczkowski

Zubaid Rafique

...

2024

First-year follow-up costs of myocardial infarction management in Poland from payer's perspective

Polish Heart Journal (Kardiologia Polska)

Anna Skowrońska

Siamala Sinnadurai

Paweł Teisseyre

Patrycja Gryka

Agnieszka Doryńska

...

2024/2/2

Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein (a) levels

Archives of Medical Science: AMS

Bożena Sosnowska

Janina Stepinska

Przemyslaw Mitkowski

Agata Bielecka-Dabrowa

Beata Bobrowska

...

2024

Achieving Cardiovascular Risk Management Goals and Patient Quality of Life

Journal of Cardiovascular Development and Disease

Agata Kosobucka-Ozdoba

Łukasz Pietrzykowski

Piotr Michalski

Jakub Ratajczak

Klaudyna Grzelakowska

...

2024/1/31

Survival in nonagenarians with acute myocardial infarction in 2014–2020: A nationwide analysis

Polish Heart Journal (Kardiologia Polska)

Małgorzata Kupisz-Urbańska

Piotr Jankowski

Roman Topór-Mądry

Michał Chudzik

Mariusz Gąsior

...

2023

PCSK9 inhibition during the inflammatory stage of SARS-CoV-2 infection

Journal of the American College of Cardiology

Eliano P Navarese

Przemysław Podhajski

Paul A Gurbel

Klaudyna Grzelakowska

Eleonora Ruscio

...

2023/1/24

TCT-74 Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With In-Stent Restenosis in Small Coronary Arteries

Journal of the American College of Cardiology

Patrycja Woźniak

Rafał Wolny

Rafał Januszek

Jacek Bil

Miłosz Jaguszewski

...

2023/10/24

Andexanet alfa—Recommendations for clinical use. Multidisciplinary experts’ standpoint

Cardiology Journal

Jacek Kubica

Piotr Adamski

Robert Gajda

Mariusz Gąsior

Marek Gierlotka

...

2023

Therapeutic strategies targeting metabolic syndrome

Medical Research Journal

Jacek Kubica

2023

Platelet-to-lymphocyte ratio as a prognostic biomarker for COVID-19 severity: a single center retrospective data analysis and systematic review with meta-analysis of 187 studies

Michal Matuszewski

Lukasz Szarpak

Michal Pruc

Agnieszka Pedrycz-Wieczorska

Mazlum Kilic

...

2023/9/4

Inhibitors of sodium-glucose transport protein 2: A new multidirectional therapeutic option for heart failure patients

Cardiology Journal

Jacek Kubica

Aldona Kubica

Klaudyna Grzelakowska

Wioleta Stolarek

Zofia Grąbczewska

...

2023

Early administration of LEvosimendan in Patients witH decompensAted chroNic hearT failure (ELEPHANT) study. Rationale and protocol of the study

Medical Research Journal

Jacek Kubica

Krzysztof Pstrągowski

Aldona Kubica

Tomasz Topoliński

Robert Gajda

...

2023

See List of Professors in Jacek Kubica, MD PhD, FESC (orcid.org/0000-0001-8250-754X; Web of Science ResearcherID D-6906-2014) University(Uniwersytet Mikolaja Kopernika w Toruniu)

Co-Authors

H-index: 117
Stefan James

Stefan James

Uppsala Universitet

H-index: 101
Massimo Volpe

Massimo Volpe

Sapienza Università di Roma

H-index: 81
Dr. Bernd Jilma

Dr. Bernd Jilma

Medizinische Universität Wien

H-index: 36
Marek Gierlotka

Marek Gierlotka

Uniwersytet Opolski

H-index: 30
Aldona Kubica, PhD, FAHA Orcid.org/0000-0002-4608-0881

Aldona Kubica, PhD, FAHA Orcid.org/0000-0002-4608-0881

Uniwersytet Mikolaja Kopernika w Toruniu

H-index: 28
Michał Marszałł

Michał Marszałł

Uniwersytet Mikolaja Kopernika w Toruniu

academic-engine